Tracey Walker
Hep C drugs could increase Medicare Part D spending by 11% in 2015
If 15% to 30% of HCV-infected beneficiaries receive treatment in 2015 with the cost of treatment averaging $84,000, Medicare Part D could increase between $2.9 billion and $5.8 billion
Broader-spectrum antibiotics over-prescribed in ambulatory settings
The majority of antibiotics prescribed for adults in ambulatory care settings are broad-spectrum agents, most commonly fluoroquinolones and macrolides. These are frequently prescribed for conditions where no antibiotic therapy is needed at all, such as for bronchitis and colds, which are caused by viruses, according to a study published online July 25, 2013, in the Journal of Antimicrobial Chemotherapy.
New HIV drug approved
FDA this week approved integrase strand transfer inhibitor dolutegravir (Tivicay, ViiV Healthcare , GlaxoSmithKline) to treat HIV-1 infection.
Treatment of bipolar depression now available with Latuda approval
FDA approved two new indications for the use of lurasidone HCl (Latuda, Sunovion and Dainippon Sumitomo Pharma) as monotherapy and adjunctive therapy with either lithium or valproate, for adults with bipolar depression.
FDA approves Vibativ for hospitalized patients with bacterial pneumonia
FDA has expanded the use of telavancin (Vibativ, Theravance) to treat adult patients with hospital-acquired and ventilator-associated bacterial pneumonia caused by susceptible isolates of Staphylococcus aureus when alternative treatments are not suitable.
New test identifies HCV genotypes
FDA approved a test that identifies the genotype of hepatitis C virus (HCV) that a patient is carrying.
FDA officially approves Plan B One-Step for all women
FDA has approved the use of Plan B One-Step (levonorgestrel) as a nonprescription product for all women of child-bearing potential. This action complies with the April 5, 2013 order of the United States District Court in New York to make levonorgestrel-containing emergency contraceptives available as an over-the-counter (OTC) product without age or point-of-sale restrictions.
FDA investigating Zyprexa Relprevv deaths
FDA is investigating 2 unexplained deaths in patients who received an intramuscular injection of the antipsychotic drug Zyprexa Relprevv (olanzapine pamoate), according to an FDA Drug Safety Communication.
ASCO: Lipid-lowering agents linked to improved survival in endometrial cancer
Endometrial cancer patients reduced their chance of death by 84% with the use of statins and aspirin, according to a new study by researchers at Montefiore Einstein Center for Cancer Care.
Crizotinib better than standard chemotherapy in some patients, study says
In a phase 3 study of previously treated patients with anaplastic lymphoma kinase-positive advanced non-small cell lung cancer, crizotinib (Xalkori, Pfizer) more than doubled median progression free survival than when treated with standard chemotherapy, according to a study published June 1, 2013 online in New England Journal of Medicine.

Poll